Cogent Biosciences Statistics
NASDAQ: COGTHealthcareBiotechnologyUSD
30.08-0.06 (-0.20%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Cogent Biosciences by the numbers
Cogent Biosciences has a market capitalization of $5.22 billion based on 173.52M shares outstanding. With trailing EPS of $-2.16, Cogent Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.1% below its 50-day average and 17.0% below its 200-day average.
Average daily trading volume is 1.90M shares, or about $57.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
COGT valuation vs. peer median
| Metric | COGT | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.22B | $3.10B | +68% |
| Avg. volume | 1.90M | 1.27M | +49% |
Peer median across 8 companies: TVTX, EWTX, IDYA, PGEN, ABVX, IMNM, VRDN, VCEL.
Valuation
- Market cap
- $5.22B
- EPS (TTM)
- $-2.16
- Shares outstanding
- 173.52M
Price and trading
- Previous close
- 30.14
- Open
- 29.71
- Day range
- 28.69 – 30.66
- 52-week range
- 13.78 – 43.73
- 52-week change
- +93.07%
- Beta
- —
- Volume
- 3.64M
- Average volume
- 1.90M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 5.22B
- Forward Pe
- -27.05
- Eps
- -2.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.73
- Week52 Low
- 13.78
- Avg Volume
- 1.90M
- Shares Outstanding
- 173.52M
- Ma50
- 35.44
- Ma200
- 36.24
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -31.21%
- Pct From52w Low
- 118.29%